Publication

Does chronic occupational exposure to volatile anesthetic agents influence the rate of neutrophil apoptosis?

Goto, Y
Gallagher, J
Fanning, N
Wang, J
McCusker, S
Redmond, P
Shorten, G
Advisors
Editors
Other Contributors
Date
2012-02-03T15:12:52Z
Date Submitted
Keywords
Other Subjects
Subject Mesh
Adult
*Anesthesiology
Anesthetics, Inhalation/*adverse effects/analysis
Apoptosis/*drug effects
Female
Fluorescein-5-isothiocyanate
Fluorescent Dyes
Humans
Isoflurane/adverse effects/analysis
Male
Methyl Ethers/adverse effects/analysis
Neutrophils/*drug effects
Nitrous Oxide/adverse effects/analysis
Occupational Exposure/*adverse effects/analysis
Time Factors
Ventilation
Planned Date
Start Date
Collaborators
Principal Investigators
Alternative Titles
Publisher
Abstract
PURPOSE: The purpose of this preliminary investigation was to determine whether the rate of neutrophil apoptosis in health care workers is influenced by exposure to volatile anesthetic agents. METHODS: Percentage neutrophil apoptosis (Annexin-V FITC assay) was measured in health care workers (n = 20) and unexposed volunteers (n = 10). For the health care workers, time weighted personal exposure monitoring to N2O, sevoflurane and isoflurane was carried out. RESULTS: The sevoflurane and isoflurane concentrations to which health care workers were exposed were less than recommended levels in all 20 cases. Percent apoptosis was less at 24 (but not at one and 12) hr culture in health care workers [50.5 (9.7)%; P = 0.008] than in unexposed volunteers [57.3 (5.1)%]. CONCLUSION: Inhibition of neutrophil apoptosis at 24 hr culture was demonstrated in health care workers chronically exposed to volatile anesthetic agents. Exposure was well below recommended levels in the both scavenged and unscavenged work areas in which the study was carried out. Further study is required to assess the effect of greater degrees of chronic exposure to volatile anesthetic agents on neutrophil apoptosis.
Language
eng
ISSN
0832-610X (Print)
0832-610X (Linking)
eISSN
ISBN
DOI
10.1007/BF03020952
PMID
10764182
PMCID
Sponsorships
Funding Sources
Funding Amounts
Grant Identifiers
Methodology
Duration
Ethical Approval